Kristin Boulier, MD
Cardiovascular Disease (Cardiology) · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Boulier’s office at (650) 962-4690 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$34,620
Medicare paid this office $34,620 for 125 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 42 | $8,624 | $205 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $7,498 | $469 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 16 | $2,363 | $76 |
| Return visit (30+ min) | 13 | $1,608 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,340 | $71 |
See all 8 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 42 | $8,624 | $205 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $7,498 | $469 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 16 | $2,363 | $76 |
| Return visit (30+ min) | 13 | $1,608 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,340 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,281 | $116 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 17 | $1,079 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $183 | $14 |
Who their Medicare patients are
125 Original Medicare patients in 2024. Average age 78 · Women 51% · Also on Medicaid 15% · Health risk score 1.13. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 45% · Atrial fibrillation 33% · Diabetes 27% · Chronic kidney disease 26% · Heart failure 25% · Cancer 14% · COPD 13% · Depression 12% · Stroke 12%.
The office billed $138,281, Medicare allowed $43,711 and paid $34,620; for 271 services of 34 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$16,544
Pharmacies billed $16,544 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 76) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
62 generic and 14 brand-name prescriptions · $16,544 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amlodipine Besylate | 11 | $75 | $7 |
Year by year
| 2024 | 76 | 37 | 0% (0) | 18% | $16,544 |
| 2023 | 29 | None | 0% (0) | None | $12,258 |
| 2021 | 49 | None | 0% (0) | None | $3,911 |
| 2020 | 21 | None | 0% (0) | None | $2,429 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 2 drugs
| Metoprolol | 11 | $612 | $56 |
| Amlodipine Besylate | 11 | $104 | $9 |
Money from drug and device companies
$931 in 2025
| 2025 | 11 | 24 | None | $931 |
| 2024 | 3 | 3 | None | $102 |
| 2022 | 1 | 1 | None | $130 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $207 | 2 payments
|
| Medtronic | Omniasecure Mri Surescan | $163 | 3 payments
|
| Biosense Webster | Carto 3 | $147 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $118 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $100 | 4 payments
|
| Amgen | Repatha | $91 | 4 payments
|
See all 23 published payments
| Biosense Webster | Meals · 2025-12-12 | Carto 3 | $147 |
| Boston Scientific | Meals · 2025-12-09 | Watchman Flx | $26 |
| Amgen | Meals · 2025-11-14 | Repatha | $19 |
| Abbott Laboratories | Meals · 2025-11-11 | Amplatzer Amulet | $23 |
| Cleerly | Meals · 2025-10-21 | Cleerly Ischemia | $16 |
| Medtronic | Meals · 2025-10-14 | Aurora Ev-Icd Mri Surescan | $58 |
| Amgen | Meals · 2025-10-07 | Repatha | $31 |
| Medtronic | Meals · 2025-10-01 | Omniasecure Mri Surescan | $82 |
| Octapharma USA | Meals · 2025-09-10 | Fibryga | $17 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-19 | Jardiance | $26 |
| Heartflow | Meals · 2025-08-05 | Ffrct | $40 |
| Edwards Lifesciences | Meals · 2025-06-27 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $22 |
| Novartis Pharmaceuticals | Meals · 2025-06-26 | Leqvio | $23 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-24 | Jardiance | $19 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-29 | Jardiance | $31 |
| Novartis Pharmaceuticals | Meals · 2025-05-20 | Leqvio | $35 |
| Medtronic | Meals · 2025-04-22 | Symplicity G3 | $23 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-14 | Jardiance | $24 |
| Amgen | Meals · 2025-03-20 | Repatha | $19 |
| Heartflow | Meals · 2025-03-19 | Ffrct | $167 |
| Novartis Pharmaceuticals | Meals · 2025-02-28 | Leqvio | $29 |
| Amgen | Meals · 2025-02-06 | Repatha | $22 |
| Novartis Pharmaceuticals | Meals · 2025-01-21 | Leqvio | $31 |
See earlier years (2024, 2022)
2024: $102
| Cleerly | Cleerly Labs | $66 | 1 payment
|
| Amgen | Repatha | $18 | 1 payment
|
| Heartflow | Ffrct | $17 | 1 payment
|
2022: $130
| Biotronik | None | $130 | 1 payment
|
Professional record
- NPI
- 1457884959
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Cardiology (207RC0000X); Student in a training program (390200000X)
- Mailing address
- 300 Pasteur Dr, Lane 154, Stanford, CA, CA, 94305
- NPI first listed
- 2017-04-11
- NPI last updated
- 2024-11-03
- NPI record certified
- 2024-11-03
This is when the NPI record was last certified, not a medical board exam.